Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting
Veradermics, Incorporated (MANE)
Company Research
Source: Business Wire
NEW HAVEN, Conn.--(BUSINESS WIRE)--Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and dermatological conditions, today announced that three abstracts will be presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting being held in Denver, Colorado on March 27 – 31, 2026.The data to be presented include a blinded, retrospective investigator global assessment conducted by six independent dermatologists regarding the comparative perceived efficacy of VDPHL01 versus existing minoxidil formulations and the clinical potential of VDPHL01. In addition, two presentations will characterize social listening research on patient perceptions and experiences, describing general frustration with current pattern hair loss treatments.Details of the Veradermics presentations are as follows:Title: Faster Onset and Superior Efficacy of an Investigational Ex
Show less
Read more
Impact Snapshot
Event Time:
MANE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MANE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MANE alerts
High impacting Veradermics, Incorporated news events
Weekly update
A roundup of the hottest topics
MANE
News
- MANE (MANE) was upgraded by Zacks Research to "hold".MarketBeat
- Veradermics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Veradermics to Participate in Upcoming March Investor ConferencesBusiness Wire
- MANE (MANE) was upgraded by Jefferies Financial Group Inc. to "strong-buy".MarketBeat
- MANE (MANE) is now covered by Citigroup Inc.. They set a "buy" rating and a $85.00 price target on the stock.MarketBeat
MANE
Sec Filings
- 2/27/26 - Form 4/A
- 2/12/26 - Form SCHEDULE
- 2/12/26 - Form SCHEDULE
- MANE's page on the SEC website